114 related articles for article (PubMed ID: 36539455)
1. Simultaneous spectrofluorimetic determination of remdesivir and simeprevir in human plasma.
El Sharkasy ME; Tolba MM; Belal F; Walash MI; Aboshabana R
Sci Rep; 2022 Dec; 12(1):21980. PubMed ID: 36539455
[TBL] [Abstract][Full Text] [Related]
2. Spectrofluorimetric quantitative analysis of favipiravir, remdesivir and hydroxychloroquine in spiked human plasma.
Ramzy S; Abdelazim AH; Osman AO; Hasan MA
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 281():121625. PubMed ID: 35863184
[TBL] [Abstract][Full Text] [Related]
3. Green and sensitive spectrofluorimetric determination of Remdesivir, an FDA approved SARS-CoV-2 candidate antiviral; application in pharmaceutical dosage forms and spiked human plasma.
Elmansi H; Ibrahim AE; Mikhail IE; Belal F
Anal Methods; 2021 Jun; 13(23):2596-2602. PubMed ID: 34019051
[TBL] [Abstract][Full Text] [Related]
4. Micelle sensitized synchronous spectrofluorimetric approaches for the simultaneous determination of simeprevir and ledipasvir: Application to pharmaceutical formulations and human plasma.
Hamad AE; Mohammed BS; Derayea SM; El-Malla SF
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Oct; 239():118471. PubMed ID: 32474370
[TBL] [Abstract][Full Text] [Related]
5. Green fitted second derivative synchronous spectrofluorometric method for simultaneous determination of remdesivir and apixaban at Nano gram scale in the spiked human plasma.
Batubara AS; Abdelazim AH; Gamal M; Almrasy AA; Ramzy S
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Apr; 290():122265. PubMed ID: 36608515
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of favipiravir and hydroxychloroquine as FDA-approved drugs for treatment of COVID-19 using synchronous spectrofluorimetry: application to pharmaceutical formulations and biological fluids.
El Sharkasy ME; Tolba MM; Belal F; Walash M; Aboshabana R
Luminescence; 2022 Jun; 37(6):953-964. PubMed ID: 35343627
[TBL] [Abstract][Full Text] [Related]
7. Microenvironment improvement protocol for the sensitive spectrofluorimetric determination of an hepatitis C virus antiviral (Simeprevir): application to human plasma.
Derayea SM; A El Hamd M; Ali S; Samir E
Luminescence; 2020 May; 35(3):393-399. PubMed ID: 31849179
[TBL] [Abstract][Full Text] [Related]
8. First derivative synchronous spectrofluorimetric method for the simultaneous determination of propofol and cisatracurium besylate in biological fluids.
El Sharkasy ME; Walash M; Belal F; Salim MM
Luminescence; 2020 Mar; 35(2):312-320. PubMed ID: 31746124
[TBL] [Abstract][Full Text] [Related]
9. Simeprevir oxidative degradation product: Molecular modeling, in silico toxicity and resolution by synchronous spectrofluorimetry.
Attia KAM; El-Abasawi NM; El-Olemy A; Serag A
Luminescence; 2018 Mar; 33(2):382-390. PubMed ID: 29124899
[TBL] [Abstract][Full Text] [Related]
10. Conventional and first derivative synchronous spectrofluorimetric methods for the simultaneous determination of cisatracurium and nalbuphine in biological fluids.
El Sharkasy ME; Walash M; Belal F; Salim MM
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Mar; 228():117841. PubMed ID: 31784219
[TBL] [Abstract][Full Text] [Related]
11. Spectrofluorimetric determination of the anti-Covid 19 agent, remdesivir, in vials and spiked human plasma.
Attia TZ; Boushra JM; Abdel Hakiem AF; Lashien AS; Noureldeen DAM
Luminescence; 2022 Jul; 37(7):1192-1199. PubMed ID: 35548893
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2
Gammeltoft KA; Zhou Y; Duarte Hernandez CR; Galli A; Offersgaard A; Costa R; Pham LV; Fahnøe U; Feng S; Scheel TKH; Ramirez S; Bukh J; Gottwein JM
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0268020. PubMed ID: 34097489
[TBL] [Abstract][Full Text] [Related]
13. Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice.
Muturi E; Hong W; Li J; Yang W; He J; Wei H; Yang H
Int J Antimicrob Agents; 2022 Jan; 59(1):106499. PubMed ID: 34929295
[TBL] [Abstract][Full Text] [Related]
14. An eco-friendly and cost-effective HPTLC method for quantification of COVID-19 antiviral drug and co-administered medications in spiked human plasma.
Ghozzy EA; El-Enany NM; Tolba MM; El Abass SA
Sci Rep; 2024 May; 14(1):10025. PubMed ID: 38693137
[TBL] [Abstract][Full Text] [Related]
15. The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication
Shytaj IL; Fares M; Gallucci L; Lucic B; Tolba MM; Zimmermann L; Adler JM; Xing N; Bushe J; Gruber AD; Ambiel I; Taha Ayoub A; Cortese M; Neufeldt CJ; Stolp B; Sobhy MH; Fathy M; Zhao M; Laketa V; Diaz RS; Sutton RE; Chlanda P; Boulant S; Bartenschlager R; Stanifer ML; Fackler OT; Trimpert J; Savarino A; Lusic M
mBio; 2022 Apr; 13(2):e0370521. PubMed ID: 35229634
[TBL] [Abstract][Full Text] [Related]
16. Fast concurrent determination of guaifenesin and pholcodine in formulations and spiked plasma using first derivative synchronous spectrofluorimetric approach.
Roshdy A; Salam RA; Hadad G; Belal F; Elmansi H
Luminescence; 2024 Jan; 39(1):e4660. PubMed ID: 38286595
[TBL] [Abstract][Full Text] [Related]
17. Conventional and synchronous spectrofluorometric determination of the recently administered drugs for treatment of COVID-19 favipiravir and apixaban.
Elama HS; Zeid AM; Shalan SM; El-Shabrawy Y; Eid MI
Sci Rep; 2022 Dec; 12(1):21520. PubMed ID: 36513795
[TBL] [Abstract][Full Text] [Related]
18. Experimental design approach for development of spectrofluorimetric method for determination of favipiravir; a potential therapeutic agent against COVID-19 virus: Application to spiked human plasma.
Megahed SM; Habib AA; Hammad SF; Kamal AH
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Mar; 249():119241. PubMed ID: 33333412
[TBL] [Abstract][Full Text] [Related]
19. Synchronous spectrofluorimetric determination of favipiravir and aspirin at the nano-gram scale in spiked human plasma; greenness evaluation.
Batubara AS; Ainousah BE; Ramzy S; Abdelazim AH; Gamal M; Tony RM
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Oct; 299():122880. PubMed ID: 37216820
[TBL] [Abstract][Full Text] [Related]
20. Application of different spectrophotometric methods for quantitative analysis of direct acting antiviral drugs simeprevir and sofosbuvir.
Ramzy S; Abdelazim AH
Spectrochim Acta A Mol Biomol Spectrosc; 2022 May; 272():121012. PubMed ID: 35158141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
